Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Maureen E. Lane"'
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 58K, Study design and patient flow by intent to treat (ITT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ea303679dbde4a3397e161607c8dd5
https://doi.org/10.1158/1078-0432.22451307.v1
https://doi.org/10.1158/1078-0432.22451307.v1
Autor:
Linda Vahdat, Vivek Mittal, Claudia Fischbach, Maureen E. Lane, J. David Warren, Richard Zelkowitz, Elnaz Aljom, Jessica Guillaume-Abraham, Alysia Wiener, Sarah Schneider, Veronica Fitzpatrick, Marta Vallee Cobham, Diana Donovan, Anne Moore, Tessa Cigler, Ellen Chuang, Bo Ri Seo, Eleni Nackos, Sharrell B. Lee, Maureen M. Ward, Naomi Kornhauser, Amy Willis, Nancy Chan
This section contains details of all mixed models utilized in the statistical analyses. The inferential tests performed in this paper necessitates a multiple comparisons adjustment, and details of the adjustment procedure is included in this section
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536d57768d74ce9163e53345aac22105
https://doi.org/10.1158/1078-0432.22464144.v1
https://doi.org/10.1158/1078-0432.22464144.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 53K, Validation of gene expression data using QPCR compared to microarray values (data reported as fold change).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd424e4842520d88c910511e4e34e30
https://doi.org/10.1158/1078-0432.22451295.v1
https://doi.org/10.1158/1078-0432.22451295.v1
Autor:
Linda Vahdat, Vivek Mittal, Claudia Fischbach, Maureen E. Lane, J. David Warren, Richard Zelkowitz, Elnaz Aljom, Jessica Guillaume-Abraham, Alysia Wiener, Sarah Schneider, Veronica Fitzpatrick, Marta Vallee Cobham, Diana Donovan, Anne Moore, Tessa Cigler, Ellen Chuang, Bo Ri Seo, Eleni Nackos, Sharrell B. Lee, Maureen M. Ward, Naomi Kornhauser, Amy Willis, Nancy Chan
Purpose: Bone marrow–derived progenitor cells, including VEGFR2+ endothelial progenitor cells (EPCs) and copper-dependent pathways, model the tumor microenvironment. We hypothesized that copper depletion using tetrathiomolybdate would reduce EPCs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f1b4248fe0bf537c457a3ff11dd98c
https://doi.org/10.1158/1078-0432.c.6525630
https://doi.org/10.1158/1078-0432.c.6525630
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
Purpose: This phase II study evaluated bortezomib-based secondary induction and stem cell mobilization in 38 transplant-eligible patients with myeloma who had an incomplete and stalled response to, or had relapsed after, previous immunomodulatory dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414ec225af4e68b8b1d603e092292a1b
https://doi.org/10.1158/1078-0432.c.6522156.v1
https://doi.org/10.1158/1078-0432.c.6522156.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 72K, Most common all-grade and grade ≥3 AEs during DoVeD induction and bortezomib-based stem cell mobilization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7f101e675536a36b8d8b71fb9facd94
https://doi.org/10.1158/1078-0432.22451298.v1
https://doi.org/10.1158/1078-0432.22451298.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 60K, Kaplan-Meier estimates of (A)PFS and (B)OS in patients in the ITT population (N-38).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::716900104ac92767fb80db3b5a0ea5ec
https://doi.org/10.1158/1078-0432.22451304.v1
https://doi.org/10.1158/1078-0432.22451304.v1
Autor:
Linda Vahdat, Vivek Mittal, Claudia Fischbach, Maureen E. Lane, J. David Warren, Richard Zelkowitz, Elnaz Aljom, Jessica Guillaume-Abraham, Alysia Wiener, Sarah Schneider, Veronica Fitzpatrick, Marta Vallee Cobham, Diana Donovan, Anne Moore, Tessa Cigler, Ellen Chuang, Bo Ri Seo, Eleni Nackos, Sharrell B. Lee, Maureen M. Ward, Naomi Kornhauser, Amy Willis, Nancy Chan
The top panel shows the reaction chemistry of established lysyl oxidase (LOX) activity assay. The bottom panel shows the Amplex Red/HRP-based LOX activity assay that detects LOX activity in vitro.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21814513f3e3461f912d9a3469fe992d
https://doi.org/10.1158/1078-0432.22464147
https://doi.org/10.1158/1078-0432.22464147
Autor:
Linda Vahdat, Vivek Mittal, Claudia Fischbach, Maureen E. Lane, J. David Warren, Richard Zelkowitz, Elnaz Aljom, Jessica Guillaume-Abraham, Alysia Wiener, Sarah Schneider, Veronica Fitzpatrick, Marta Vallee Cobham, Diana Donovan, Anne Moore, Tessa Cigler, Ellen Chuang, Bo Ri Seo, Eleni Nackos, Sharrell B. Lee, Maureen M. Ward, Naomi Kornhauser, Amy Willis, Nancy Chan
This is the schema of the clinical study design. This is a Phase 2 trial of TM in breast cancer at high risk of recurrence. Eligible patients received TM for 2 years to achieve a target CP level of < 17 mg/dL. Primary endpoint was effect on VEGFR2+ E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089c0ca354902d5d859e85488e07edd1
https://doi.org/10.1158/1078-0432.22464153.v1
https://doi.org/10.1158/1078-0432.22464153.v1
Autor:
Linda Vahdat, Vivek Mittal, Claudia Fischbach, Maureen E. Lane, J. David Warren, Richard Zelkowitz, Elnaz Aljom, Jessica Guillaume-Abraham, Alysia Wiener, Sarah Schneider, Veronica Fitzpatrick, Marta Vallee Cobham, Diana Donovan, Anne Moore, Tessa Cigler, Ellen Chuang, Bo Ri Seo, Eleni Nackos, Sharrell B. Lee, Maureen M. Ward, Naomi Kornhauser, Amy Willis, Nancy Chan
This is the demographics table containing brief summary of baseline patient characteristics of patients enrolled on trial.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdfcd37699e7eb9871437f362a4e97a
https://doi.org/10.1158/1078-0432.22464141
https://doi.org/10.1158/1078-0432.22464141